Tag Archives: Approved

Ofev Approved for Chronic Fibrosing ILDs With Progressive Phenotype

TUESDAY, March 10, 2020 — Ofev (nintedanib) oral capsules have received the first approval for the treatment of patients with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, the U.S. Food and Drug Administration announced Monday. Ofev, a multitargeted tyrosine kinase inhibitor, was approved in 2014 to treat idiopathic pulmonary fibrosis and to… Read More »

Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer

Print this page 30 December 2019 — AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that Lynparza® (olaparib) has been approved in the US for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) metastatic pancreatic adenocarcinoma whose… Read More »

American Medical Association calls for total ban of non-FDA approved vaping products

A woman smokes an E-Cigarette at Digital Ciggz in San Rafael, California. Justin Sullivan | Getty Images The American Medical Association called for a total ban on all vaping products that haven’t been approved by the Food and Drug Administration to help quit smoking, the nation’s largest association of physicians announced Tuesday. “The recent lung… Read More »

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

An Opioid That's One Thousand Times More Potent Than Morphine Is Approved at Height of Opioid Addiction Crisis

An estimated 202,600 Americans died from opioid overdoses between 2002 and 2015,1 and drug overdoses are now the leading cause of death among Americans under the age of 50.2 Despite all the public warnings and national efforts to rein in this lethal trend, overdose cases admitted into emergency rooms still increased by more than 30… Read More »

FDA Approved Woods Lamp Skin Examination Dermatology Skin Analyzer to Diagnosis Skin Disease

Appliation: The Wood’s lamp test is done to help to detect several conditions affecting the skin, including: Bacterial infections,Fungal infections,Ectoparasites infestations,Skin coloring changes Features * Small size, light weight, easy for patient to carry; * Products using UVA light source, which can be used to detect pigment abnormalities, skin infections, porphyry in metabolism abnormalities. Avoiding… Read More »